Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 67 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01EY025383
National Institutes of Health
Grant: R01EY012601
National Institutes of Health
Grant: R01EY028858
National Institutes of Health
Grant: R01EY032753
National Institutes of Health
Grant: R01EY028037
NEI NIH HHS
Grant: P30 EY003039
NIH HHS
Grant: R01EY025383, R01EY012601, R01EY028858, R01EY028037
National Institutes of Health
Grant: 5R01EY028037-04
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathy
National Institutes of Health
Grant: 5R01EY028858-03
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy
National Institutes of Health
Grant: 5R01EY012601-09
Endothelial precursor dysfunction in development of diabetic acellular capillary
National Institutes of Health
Grant: 5R01EY025383-04
LXR as a Novel Therapeutic Target in Diabetic Retinopathy
National Institutes of Health
Grant: 5R01EY032753-04
ACE2 on gut barrier dysfunction and BRB disruption
FWCI
4.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals